Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Behavioral Neuroscience"
DOI: 10.3389/fnbeh.2022.938044
Abstract: Treatment options for chronically aggressive individuals remain limited despite recent medical advances. Traditional pharmacological agents used to treat aggression, such as atypical antipsychotics, have limited efficacy and are often replete with dangerous side effects. The… read more here.
Keywords: ketamine memantine; nmda receptor; promises pitfalls; aggression ... See more keywords